Physician profile
James B Daugharthy
NPI 1598891152
$2,539.86
in general payments reported to CMS, 2019-2025
8 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $278 · 2021: $309 · 2022: $432 · 2023: $893 · 2024: $44.06 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,606.41 | 2021-2025 | Endurant Iis, Avalus, Valiant Captivia |
| Medtronic Vascular, INC. | $557.36 | 2019-2020 | |
| Penumbra, INC. | $125.00 | 2023 | Ruby Coil |
| Getinge USA Sales, LLC | $91.37 | 2019-2020 | |
| Ethicon US, LLC | $71.42 | 2023 | Prolene, Vistaseal |
| Kci USA, INC. | $40.58 | 2020-2023 | Prevena |
| Edwards Lifesciences Corporation | $28.24 | 2019-2020 | |
| Atricure, INC. | $19.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Daugharthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.